Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-015934
Filing Date
2021-08-16
Accepted
2021-08-16 17:16:48
Documents
2
Period of Report
2021-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1731
2 POWER OF ATTORNEY poa_waddill.htm EX-24.1 7402
  Complete submission text file 0001567619-21-015934.txt   10539
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address
Waddill William D. (Reporting) CIK: 0001553338 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39402 | Film No.: 211179822